Evidence map›Paper›PMID 34608220›Full record

ArticleScientific reports2021

Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia.

Jeremy M Schraw, J P Woodhouse, Melanie B Bernhardt, Olga A Taylor, Terzah M Horton, Michael E Scheurer, M Fatih Okcu, Karen R Rabin, Philip J Lupo, Austin L Brown

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Metabolism of asparagine in the physiological state and cancer.Cell communication and signaling : CCS · 2024
    Review
  11. Review
  12. [Recent research on cognitive impairment in children with acute lymphoblastic leukemia].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Review
  13. Article
  14. Application of Metabolomics in Childhood Leukemia Diagnostics.Archivum immunologiae et therapiae experimentalis · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jeremy M SchrawSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. jeremy.schraw@bcm.edu.
J P WoodhouseSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Melanie B BernhardtSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Olga A TaylorSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Terzah M HortonSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Michael E ScheurerSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
M Fatih OkcuSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Karen R RabinSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Philip J LupoSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Austin L BrownSection of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · USTexas Children's Hospital · US

Funding

Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic LeukemiaK07CA218362 · NCI · BAYLOR COLLEGE OF MEDICINE · PI BROWN, AUSTIN L · 2018 to 2022
$758k
NCI NIH HHS K07 CA218362
6 · The paper itself

Abstract

Metabolomics may shed light on treatment response in childhood acute lymphoblastic leukemia (ALL), however, most assessments have analyzed bone marrow or cerebrospinal fluid (CSF), which are not collected during all phases of therapy. Blood is collected frequently and with fewer risks, but it is unclear whether findings from marrow or CSF biomarker studies may translate. We profiled end-induction plasma, marrow, and CSF from N = 10 children with B-ALL using liquid chromatography-mass spectrometry. We estimated correlations between plasma and marrow/CSF metabolite abundances detected in ≥ 3 patients using Spearman rank correlation coefficients (r

Indexed as

BiomarkersMetabolomeMetabolomicsAdolescentBone MarrowChildChild, PreschoolComputational BiologyFemaleHumansInfantMalePrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrognosisBiomarkers

Identifiers

PMID34608220
PMCPMC8490393
OpenAlexW3204216602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.